Quest Diagnostics Reports Third Quarter 2019 Financial Results

Go back to Quest Diagnostics Reports Third Quarter 2019 Financial Results

Quest Diagnostics (DGX) Tops Q3 EPS by 5c, Revenues Beat; Revises FY19 EPS/Revenue Guidance

October 22, 2019 6:49 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.76, $0.05 better than the analyst estimate of $1.71. Revenue for the quarter came in at $1.96 billion versus the consensus estimate of $1.94 billion.

"We had a solid quarter of top and bottom-line growth," said Steve Rusckowski, Chairman, CEO and... More